Platform Therapeutics, Inc.
PrivateLast Round
Seed
Aug 12, 2026
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Platform Therapeutics, Inc. operates in Healthcare & Life Sciences and is based in Andover, Massachusetts.
Platform Therapeutics, Inc. is a clinical-stage life-science company that develops therapies to mitigate the toxic effects of chemotherapy and alleviate muscle cramps during dialysis.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Platform Therapeutics, Inc. Comparables
Compare Platform Therapeutics, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Ting Therapeutics | 77% | |
| Acousia Therapeutics GmbH | 76% | |
| Regeneron Pharmaceuticals | 74% |
For institutional investors. Book with your work email.
Platform Therapeutics, Inc. Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 12, 2026
Raised $1.75M in a Seed Round.
For institutional investors. Book with your work email.
Platform Therapeutics, Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Platform Therapeutics, Inc.'s valuation, stock price, and market status.
Is Platform Therapeutics, Inc. a public or private company?
Platform Therapeutics, Inc. is a private company.
What is the current stock price of Platform Therapeutics, Inc.?
Platform Therapeutics, Inc. is a private company, so its shares have no public market price. Caplight tracks Platform Therapeutics, Inc.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Platform Therapeutics, Inc. worth (valuation)?
Valuation information for Platform Therapeutics, Inc. is not publicly available.
Can I buy Platform Therapeutics, Inc. stock?
Platform Therapeutics, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Platform Therapeutics, Inc.'s last funding round?
Platform Therapeutics, Inc.'s most recent funding round was Seed on August 12, 2026.
Who are the main investors in Platform Therapeutics, Inc.?
Investor information for Platform Therapeutics, Inc. is not publicly disclosed.
Will Platform Therapeutics, Inc. IPO soon?
No public IPO plans have been announced for Platform Therapeutics, Inc..
How can I track Platform Therapeutics, Inc. secondary market activity?
Caplight tracks bids, offers, and trades in Platform Therapeutics, Inc.'s shares on secondary markets.